Caixin
Oct 29, 2022 08:00 AM

Shenzhen Kangtai Biological Products Co.,Ltd.’s Net Profit Dropped 80.4% in First Three Quarters of 2022

00:00
00:00/00:00
Listen to this article 1x

Shenzhen Kangtai Biological Products Co.,Ltd. (深圳康泰生物制品股份有限公司) (300601.SZ) reported a net profit of 203.1 million yuan in the first three quarters of 2022, down 80.4% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 13.9 billion yuan in total assets and 4.6 billion yuan in total liabilities, with a liability-to-asset ratio of 32.9%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning
00:00
00:00/00:00